Alaproclate (developmental code name GEA-654) is a drug that was being developed as an antidepressant by the Swedish pharmaceutical company Astra AB (now AstraZeneca) in the 1970s.
The development of Alaproclate, a potential antidepressant, was undertaken by Astra AB (now AstraZeneca) during the 1970s.